![Roy Proujansky](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Roy Proujansky
Directeur/Membre du Conseil chez Rheonix, Inc.
Profil
Roy Proujansky is currently the CEO-Delaware Valley Operations & Executive VP at Dupont Hospital for Children and also serves as the Director at Rheonix, Inc. He previously worked as the Chairman-Pediatrics Department & Associate Dean at Sidney Kimmel Medical College from 2000 to 2006, as the Chief Operating Officer & EVP-Patient Operations at The Nemours Foundation from 2006 to 2013, and as an Independent Director at 9 Meters Biopharma, Inc. from 2018 to 2020.
He also worked as an Assistant Professor at the University of Pittsburgh School of Medicine.
Dr. Proujansky received his undergraduate degree from Northwestern University in 1978, his doctorate from Northwestern University in 1980, and his MBA from the University of Massachusetts.
Postes actifs de Roy Proujansky
Sociétés | Poste | Début |
---|---|---|
Dupont Hospital for Children | Corporate Officer/Principal | 01/07/2013 |
Rheonix, Inc.
![]() Rheonix, Inc. Medical SpecialtiesHealth Technology Rheonix, Inc. operates microfluidic platform for the molecular diagnostics industry. It is committed to improving standards of care by making molecular diagnostics available to more people, in more places, more often. The firm's platform performs fully automated, complex molecular assays in an easy to use and economical format on the Rheonix CARD cartridge. The company was founded by Greg Galvin in 2007 and is headquartered in Ithaca, NY. | Directeur/Membre du Conseil | 29/01/2021 |
Anciens postes connus de Roy Proujansky
Sociétés | Poste | Fin |
---|---|---|
9 METERS BIOPHARMA, INC. | Directeur/Membre du Conseil | 30/06/2020 |
The Nemours Foundation
![]() The Nemours Foundation Investment Trusts/Mutual FundsMiscellaneous The Nemours Foundation is a pediatric health system is engaged in activities that promote higher standards of children's health. It offers a spectrum of clinical treatment, research, advocacy, and educational health and prevention services extending to families in the communities it serves. Nemours Foundation was founded in Alfred I. duPont in 1936. Its headquarters are located in Jacksonville, FL. | Directeur des opérations | 01/07/2013 |
Sidney Kimmel Medical College | Corporate Officer/Principal | 01/01/2006 |
University of Pittsburgh School of Medicine | Corporate Officer/Principal | - |
Formation de Roy Proujansky
Northwestern University | Doctorate Degree |
University of Massachusetts | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
9 METERS BIOPHARMA, INC. | Health Technology |
Entreprise privées | 3 |
---|---|
The Nemours Foundation
![]() The Nemours Foundation Investment Trusts/Mutual FundsMiscellaneous The Nemours Foundation is a pediatric health system is engaged in activities that promote higher standards of children's health. It offers a spectrum of clinical treatment, research, advocacy, and educational health and prevention services extending to families in the communities it serves. Nemours Foundation was founded in Alfred I. duPont in 1936. Its headquarters are located in Jacksonville, FL. | Miscellaneous |
Dupont Hospital for Children | |
Rheonix, Inc.
![]() Rheonix, Inc. Medical SpecialtiesHealth Technology Rheonix, Inc. operates microfluidic platform for the molecular diagnostics industry. It is committed to improving standards of care by making molecular diagnostics available to more people, in more places, more often. The firm's platform performs fully automated, complex molecular assays in an easy to use and economical format on the Rheonix CARD cartridge. The company was founded by Greg Galvin in 2007 and is headquartered in Ithaca, NY. | Health Technology |